| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 933,000 | 937,000 | 1,384,000 | 1,261,000 | | Cost of Revenue | 886,000 | (111,000) | 769,000 | 459,000 | | | Gross Profit | 47,000 | 1,048,000 | 615,000 | 802,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (454,000) | 587,000 | 64,000 | 376,000 | | Non Recurring | 10,000 |
-
| (10,000) | (10,000) | | Others | 149,000 | 144,000 | 136,000 | 132,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 353,000 | 317,000 | 425,000 | 304,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23,000 | 14,000 | 9,000 | 36,000 | | Earnings Before Interest And Taxes | 425,000 | 371,000 | 601,000 | 376,000 | | Interest Expense | 160,000 | 146,000 | 150,000 | 166,000 | | Income Before Tax | 265,000 | 225,000 | 451,000 | 210,000 | | Income Tax Expense | 54,000 | 67,000 | 139,000 | 43,000 | | Minority Interest | (55,000) |
-
|
-
| (17,000) | | | | Net Income From Continuing Ops | 211,000 | 158,000 | 312,000 | 167,000 | | | Non-recurring Events | | Discontinued Operations | 1,000 | (1,000) | 3,000 | 4,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 157,000 | 157,000 | 315,000 | 171,000 | | Preferred Stock And Other Adjustments | 34,000 | (17,000) | (17,000) |
-
| | | Net Income Applicable To Common Shares | $191,000 | $140,000 | $298,000 | $171,000 |
|
0.02% Nasdaq 
0.33%
Income Statement
